Medications for Addiction Treatment (MAT): Clinical Strategies for Engagement, Selection, and Initiation
Medications for Addiction Treatment (MAT): Clinical Strategies for Engagement, Selection, and Initiation
Novel Drugs of Abuse: What Clinicians Need to Know
Novel drugs are synthetic illicit drugs sometimes referred to as designer drugs and are often sold as legal, safe, nondrug products, frequently escaping regulation, resulting in delays in professionals and legislators recognizing their use and impacts.
Hallucinogens: What Clinicians Need to Know
This session will provide an overview of various substances comprising the category of hallucinogens, their intoxication and withdrawal symptoms, and co-occurring mental health and physical health concerns.
Alcohol and Benzodiazepines: What Clinicians Need to Know
More and more clinicians are receiving referrals for grieving clients asking for support in their bereavement process. The current course aims to provide clinicians with a grounding in psychoeducation and theory behind grief responses in order to increase clinician confidence in working with clients who are experiencing bereavement.